Sale!

FISH – NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test Cost

Original price was: 3,120 د.إ.Current price is: 2,810 د.إ.

-10%

The FISH (Fluorescence In Situ Hybridization) test for Non-Small Cell Lung Cancer (NSCLC) targeting the ALK1 and ROS1 genes is a critical diagnostic tool used to identify specific genetic abnormalities in lung cancer cells. This test is particularly important for patients with NSCLC, as the presence of alterations in the ALK1 and ROS1 genes can significantly influence treatment decisions and outcomes. By using fluorescent probes, the FISH test can accurately detect rearrangements in these genes, which are known to drive tumor growth in a subset of lung cancer patients.

Administered at DNA Labs UAE, a leading facility in genetic testing, the FISH test for NSCLC ALK1 and ROS1 is conducted with high precision and accuracy, ensuring reliable results for patients and healthcare providers. The cost of the test is set at 2810 AED, reflecting the sophisticated technology and expertise required to perform this specialized diagnostic procedure.

Patients who are found to have alterations in the ALK1 or ROS1 genes through this test may be eligible for targeted therapies, which can be more effective and have fewer side effects compared to traditional chemotherapy. Thus, the FISH test for NSCLC ALK1 and ROS1 at DNA Labs UAE represents a crucial step in the personalized treatment approach for lung cancer, offering hope for improved patient outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FISH – NSCLC NON-SMALL CELL LUNG CANCER ALK1 and ROS1 Test

Test Name: FISH – NSCLC NON-SMALL CELL LUNG CANCER ALK1 and ROS1 Test

Components: Price: 2810.0 AED

Sample Condition: Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Tissue block must contain 10% tumor tissue. Duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.

Report Delivery: Sample Daily by 4 pm; Report 4 Working days

Method: FISH

Test type: Cancer

Doctor: Oncologist

Test Department: CYTOGENETICS

Pre Test Information: Duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.

Test Details

The FISH (Fluorescence In Situ Hybridization) NSCLC ALK1 & ROS1 test is a diagnostic test used to detect specific genetic abnormalities in non-small cell lung cancer (NSCLC) patients. It looks for rearrangements in the ALK1 and ROS1 genes, which are known to drive the growth of cancer cells.

The test involves analyzing a tissue sample taken from a patient’s lung tumor. Special fluorescent probes are used to label the ALK1 and ROS1 genes, allowing them to be visualized under a microscope. If there is a rearrangement in either gene, the fluorescent signal will be abnormal, indicating the presence of the genetic abnormality.

Detection of ALK1 or ROS1 gene rearrangements is important for determining appropriate treatment options for NSCLC patients. These genetic abnormalities can be targeted with specific drugs known as ALK inhibitors or ROS1 inhibitors. Identifying patients with these genetic alterations helps to personalize treatment plans and improve patient outcomes.

Overall, the FISH NSCLC ALK1 & ROS1 test is a valuable tool in the management of NSCLC patients, as it provides crucial information about the genetic profile of the tumor and guides targeted therapy decisions.

Test Name FISH – NSCLC NON-SMALL CELL LUNG CANCER ALK1 and ROS1 Test
Components
Price 2810.0 AED
Sample Condition Submit Formalin fixed paraffin embedded tissue block. Ship at room temperature. Tissue block must contain 10% tumor tissue. Duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.
Report Delivery Sample Daily by 4 pm; Report 4 Working days
Method FISH
Test type Cancer
Doctor Oncologist
Test Department: CYTOGENETICS
Pre Test Information Duly filled Chromosome & FISH analysis Requisition Form (Form 17) is mandatory.
Test Details

The FISH (Fluorescence In Situ Hybridization) NSCLC ALK1 & ROS1 test is a diagnostic test used to detect specific genetic abnormalities in non-small cell lung cancer (NSCLC) patients. It looks for rearrangements in the ALK1 and ROS1 genes, which are known to drive the growth of cancer cells.

The test involves analyzing a tissue sample taken from a patient’s lung tumor. Special fluorescent probes are used to label the ALK1 and ROS1 genes, allowing them to be visualized under a microscope. If there is a rearrangement in either gene, the fluorescent signal will be abnormal, indicating the presence of the genetic abnormality.

Detection of ALK1 or ROS1 gene rearrangements is important for determining appropriate treatment options for NSCLC patients. These genetic abnormalities can be targeted with specific drugs known as ALK inhibitors or ROS1 inhibitors. Identifying patients with these genetic alterations helps to personalize treatment plans and improve patient outcomes.

Overall, the FISH NSCLC ALK1 & ROS1 test is a valuable tool in the management of NSCLC patients, as it provides crucial information about the genetic profile of the tumor and guides targeted therapy decisions.